| JTS2200006 | OA-Arg-甘精胰岛素 | | Active ingredient | Biological Products | Disposable Import Drug Application | 2022-02-18 | | Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JTS2000032 | OA-Arg-甘精胰岛素 | | Active ingredient | Biological Products | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | Approval Completed-Pending Certificated | 2020-08-24 | view |
| CXSS1700020 | 甘精胰岛素 | insulin glargine | Injection | Biological Products(7) | New Drug Application | 2017-12-11 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | In Review | 2017-12-08 | view |
| CXSL1500049 | 甘精胰岛素 | insulin glargine | Injection | Biological Products(15) | New Drug Application | 2015-10-23 | 辽宁博鳌生物制药有限公司 | Liaoning Boao Biological Pharmaceutical Co Ltd | Certificate Issued | 2017-04-07 | view |
| CXSL1600005 | 甘精胰岛素 | insulin glargine | Injection | Biological Products(15) | New Drug Application | 2016-03-17 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2017-01-11 | view |
| JTS2000033 | 甘精胰岛素 | insulin glargine | Injection | Biological Products | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | Certificate Issued | 2020-08-24 | view |
| CXSS1300002 | 甘精胰岛素 | insulin glargine | Injection | Biological Products(15) | New Drug Application | 2013-02-27 | 珠海联邦制药股份有限公司 | Zhuhai United Laboratories Co Ltd | Certificate Issued | 2017-01-11 | view |
| CXSL1400034 | 甘精胰岛素 | insulin glargine | Injection | Biological Products(15) | New Drug Application | 2014-04-28 | 宜昌长江药业有限公司 | Yichang HEC Changjiang Pharmaceutical Co Ltd | Certificate Issued | 2016-08-04 | view |
| JXSL1500034 | 甘精胰岛素 | insulin glargine | Injection | Biological Products | Import Drug Application | 2015-07-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2017-06-09 | view |
| JXSL1200063 | 甘精胰岛素 | insulin glargine | Injection | Biological Products | Import Drug Application | 2012-10-12 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2014-07-31 | view |
| CXSL1200107 | 甘精胰岛素 | insulin glargine | Injection | Biological Products(7) | New Drug Application | 2013-02-19 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2014-06-17 | view |
| JTS2200010 | 甘精胰岛素 | insulin glargine | Injection | Biological Products | Disposable Import Drug Application | 2022-03-11 | | Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
| JXSS1800004 | 甘精胰岛素 | insulin glargine | Injection | Biological Products | Import Drug Application | 2018-04-16 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | In Review | 2019-12-06 | view |
| CXSS1900027 | 甘精胰岛素 | insulin glargine | Injection | Biological Products(15) | New Drug Application | 2019-07-02 | 辽宁博鳌生物制药有限公司 | Liaoning Boao Biological Pharmaceutical Co Ltd | In Review | 2019-07-01 | view |
| CXSL1200025 | 甘精胰岛素 | insulin glargine | Injection | Biological Products(7) | New Drug Application | 2012-05-17 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2013-01-30 | view |
| JXSL1700044 | 甘精胰岛素利司那肽注射液 | insulin glargine;lixisenatide | Injection | Biological Products | Import Drug Application | 2017-08-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2018-08-07 | view |
| JXSL1700045 | 甘精胰岛素利司那肽注射液 | insulin glargine;lixisenatide | Injection | Biological Products | Import Drug Application | 2017-08-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | Certificate Issued | 2018-08-07 | view |
| JXSL1700037 | 甘精胰岛素利司那肽注射液 | insulin glargine;lixisenatide | Injection | Biological Products | Import Drug Application | 2017-07-19 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Groupe | Certificate Issued | 2018-08-07 | view |
| JXSL2101131 | 甘精胰岛素利司那肽注射液1:1 | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Import Drug Application | 2021-11-17 | | Sanofi KK;Sanofi (China) Investment Co Ltd | | | view |
| JXSS2101024 | 甘精胰岛素利司那肽注射液1:1 | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Import Drug Application | 2021-09-29 | | Sanofi KK;Sanofi-Aventis Deutschland GmbH;Sanofi (China) Investment Co Ltd | | | view |
